RapidAI, a health tech company specializing in stroke imaging, has received clearance from the FDA for its Rapid ASPECTS neuroimaging analysis device.
The product was designed to improve physicians’ interpretations of Non-Contrast CT (NCCT) scans using the automated ASPECT score, according to the company. It uses the Alberta Stroke Program Early CT Scoring (ASPECTS) and machine learning to come...
